Sanofi name change sees Aventis dropped
pharmafile | May 9, 2011 | News story | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Sanofi, Sanofi-Aventis
Sanofi-Aventis will now just be known as Sanofi after the French pharma company’s shareholders agreed to change its name.
Following the vote at its combined general shareholder meeting Sanofi has also unveiled its new visual identity, led by new logo ‘the bird of hope’.
The company hopes the image, a planet with a bird at the centre, will illustrate its ambition to put the patient at the heart of its activities.
The now abandoned Aventis brand began life in 1999 through the combination of Germany’s Hoechst Marion Roussel and France’s Rhone-Poulenc Rorer.
That company then merged with Sanofi-Synthelabo to create Sanofi-Aventis in 2004.
Dominic Tyer
Related Content
Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia
Sanofi has announced positive results from its phase 3 LUNA 3 study, which assessed rilzabrutinib …
Sanofi shares phase 2b results for dermatitis treatment
Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study …
Sanofi to acquire Inhibrx for approximately $1.7bn
Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for …